GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a remarkable innovation in how we handle diabetes mellitus . These new drugs help imitating the body’s inherent GLP-1 hormone , which encourages glucose regulation and diminishes blood sugar production . Beyond glucose regulation, research indicate that GLP-1 medications